Mucopolysaccharidosis Type I represents a paradigmatic example of how targeted therapeutic interventions can fundamentally alter the trajectory of rare genetic diseases. This autosomal recessive lysosomal storage disorder, caused by mutations in the IDUA gene encoding alpha-L-iduronidase, results in progressive accumulation of dermatan sulfate and heparan sulfate throughout the body. The clinical spectrum encompasses three phenotypic… Read.